RenovoRx Historical Balance Sheet
RNXT Stock | USD 0.97 0.02 2.02% |
Trend analysis of RenovoRx balance sheet accounts such as Net Tangible Assets of 9.8 M, Accounts Payable of 510.4 K, Cash of 1.3 M or Non Current Assets Total of 122 K provides information on RenovoRx's total assets, liabilities, and equity, which is the actual value of RenovoRx to its prevalent stockholders. By breaking down trends over time using RenovoRx balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining RenovoRx latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RenovoRx is a good buy for the upcoming year.
RenovoRx |
About RenovoRx Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of RenovoRx at a specified time, usually calculated after every quarter, six months, or one year. RenovoRx Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of RenovoRx and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which RenovoRx currently owns. An asset can also be divided into two categories, current and non-current.
RenovoRx Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of RenovoRx assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in RenovoRx books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on RenovoRx balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of RenovoRx are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from RenovoRx's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Total Current Liabilities is comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 9.8 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (3.3 M).
2024 | 2025 (projected) | Short and Long Term Debt Total | 2.5M | 2.4M | Total Assets | 1.7M | 1.6M |
RenovoRx balance sheet Correlations
Click cells to compare fundamentals
RenovoRx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RenovoRx balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 1.9M | 16.3M | 7.3M | 1.5M | 1.7M | 1.6M | |
Other Current Liab | 1.2M | 413K | 568K | 614K | 706.1K | 666.4K | |
Total Current Liabilities | 4.1M | 938K | 1.1M | 1.2M | 1.1M | 1.3M | |
Total Stockholder Equity | (14.7M) | 15.3M | 6.2M | (3M) | (3.5M) | (3.3M) | |
Net Debt | 995K | (15.2M) | (6.4M) | (1.2M) | (1.1M) | (1.1M) | |
Retained Earnings | (15.0M) | (21.3M) | (31.2M) | (41.4M) | (37.3M) | (39.1M) | |
Accounts Payable | 162K | 525K | 534K | 561K | 645.2K | 510.4K | |
Cash | 1.8M | 15.2M | 6.4M | 1.2M | 1.3M | 1.3M | |
Cash And Short Term Investments | 1.8M | 15.2M | 6.4M | 1.2M | 1.3M | 1.3M | |
Liabilities And Stockholders Equity | 1.9M | 16.3M | 7.3M | 1.5M | 1.7M | 1.6M | |
Non Current Liabilities Total | 12.5M | 525K | 568K | 3.3M | 3.0M | 4.7M | |
Other Current Assets | 115K | 1.1M | 825K | 293K | 337.0K | 542.1K | |
Other Stockholder Equity | 315.5K | 36.6M | 37.3M | 38.4M | 44.2M | 24.8M | |
Total Liab | 16.6M | 938K | 1.1M | 4.5M | 4.0M | 5.8M | |
Net Invested Capital | (11.9M) | 15.3M | 6.2M | (3M) | (3.5M) | (3.3M) | |
Total Current Assets | 1.9M | 16.3M | 7.3M | 1.5M | 1.7M | 1.6M | |
Accumulated Other Comprehensive Income | (12.5K) | (16.3M) | 17K | 3M | 3.5M | 3.6M | |
Net Working Capital | (2.2M) | 15.3M | 6.2M | 291K | 334.7K | 317.9K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.